Industry News
StemCells, Inc. Supports National Neurotechnology Initiative Act
Applera Corporation's Board of Directors Formally Approves Proposed Separation of Its Celera Business
U.S. Patent Office Allows Another Significant VNUS Patent
Long-term worries as Applied Bio posts flat Q3
BiPar Sciences Expands Phase II Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
CLX Medical, Inc. Announces Increasing Interest and Sales of Zonda's Rapid Point of Care Test for Chlamydia
Cardima Announces Completion of $5 Million Private Placement
Vermillion Forms Clinical Steering Committee for Peripheral Artery Disease Diagnostics Program
New Survey Finds Enhanced Pain Management for Blood Draw and IV Insertions in Children Would Benefit Patients, Families and Nursing Staff
Neuralstem Sues StemCells, Inc. Over New Patent
Gilead Appoints John C. Martin as Chairman of Board of Directors; Names John F. Milligan President
Medgenics Appoints VP Clinical Affairs
Fluidigm and AME Bioscience Team Up in Nordic Distribution Deal
Lipid Sciences Broadens Intellectual Property Portfolio With Two New Patents
National Center for Victims of Crime Honors Applied Biosystems Executive with 2008 Leadership Award
ThermoGenesis Announces Amended and Restated Distribution Agreement With GE Healthcare
University of Alabama at Birmingham First in the U.S. to Treat Cancer Patients with RapidArc Radiotherapy
Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase I Clinical Data Presented at American Pain Society Meeting
Elsevier Health Sciences CEO Brian Nairn to Retire; Michael Hansen, Former CEO of Harcourt Assessment to Succeed
James T. Glover Appointed to Board of Directors of Varian, Inc.
Agilent Technologies Expands Therapeutic Nucleic Acids Manufacturing Capacity
Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference
Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
Applied Biosystems Genomic Analysis Platform Fuels New Era of Life-Sciences Research
PDL Biopharma Announces Conversion Rate Adjustment for 2.00% Convertible Senior Notes Due February 15, 2012
University of Edinburgh Human Embryonic Stem Cell Program Awarded UK Grant Funding
Questcor Moves to NASDAQ
DiscoveRx and Caliper Life Sciences Collaborate to Offer Revolutionary Solutions for Cell-Based GPCR Profiling and Lead Optimization
Curis, Inc. announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer
KaloBios Expands Senior Management Team
Applied Biosystems & Bio-Rad Gain Gene Expression Profiling Market Share
Applied Biosystems DNA Analysis Technologies Aiding Genographic Project
Applera Corporation Declares Dividend
ConforMIS Completes Executive Team With Addition of CFO
Vivus Inc files for $150 million stock offering
Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
ROXRO PHARMA's Phase III Intranasal Analgesic Data Receives Excellence Award
Senetek PLC Announces Positive Results from Pyratine-6 Clinical Trial in Patients with Acne Rosacea
Emergent BioSolutions Acquires Advanced Recombinant Protective Antigen Anthrax Vaccine Candidate and Technology
Anesiva Announces Publication of Phase III Zingo Data in the Journal Pediatrics
Cardica's C-Port Flex A Anastomosis System Facilitates Groundbreaking Port Only Robotic Beating Heart Bypass Surgery
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva in the Treatment of Psoriasis Published in the British Journal of Dermatology
McKesson Announces Settlement with DEA
IMPAX Continues to Make Progress in Filing Delinquent Periodic Reports
Nuvelo Receives Nasdaq Notification
